Mustafa Fırat Aydın

Mustafa Fırat Aydın

Auto-generated profile, based on publicly available information

Mustafa Fırat Aydın

SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, DİYARBAKIR GAZİ YAŞARGİL SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Journal of Pregnancy
Verified
Journal Article
Open access
LSLEYLA SERO
LEYLA SERO
NONilüfer Okur
Nilüfer Okur
DTDuygu Tunçel
Duygu Tunçel
MTMehmet Nur Talay
Mehmet Nur Talay
MAMustafa Fırat Aydın
Mustafa Fırat Aydın
SOSüleyman Cemil Oğlak
Süleyman Cemil Oğlak
Background: The novel coronavirus disease 2019 (COVID‐19) was more devastating in people with comorbidities such as advanced age and immunodeficiency. Another group affected by COVID‐19 was pregnant women. Immunological changes during pregnancy and conditions such as gestational diabetes and pre‐eclampsia that occur during pregnancy also have effects on the fetus. The aim of this study was to analyze the effects of PCR‐proven COVID‐19 infection during pregnancy on fetus and newborn.Methods: Between December 2019 and October 2021, data from pregnant women with COVID‐19 symptoms or a history of contact with people with COVID‐19, infected with PCR‐proven COVID‐19 virus, were analyzed retrospectively. Clinical and laboratory data of pregnant women were analyzed. Death data associated with COVID‐19 were evaluated. Clinical and laboratory findings of newborns related to COVID‐19 and mortality data related to COVID‐19 were recorded. The study received approval from the Gazi Yasargil Training and Research Hospital ethics committee (09.07.2021/853).Results: We evaluated 327 pregnant women who were followed up in our hospital and whose deliveries ended in live birth, stillbirth, miscarriage, or curettage. One hundred eighty‐five (56.6%) of the pregnant women had at least one COVID‐19‐related symptom. We evaluated the data of 306 live births, 21 intrauterine fetal deaths, and 13 postnatal deaths. Among the postnatal deaths, five infants succumbed directly due to COVID‐19 infection. A total of 23 live‐born babies (7.5%) were classified as small for gestational age (SGA), while 80 babies (26.1%) were born before 37 weeks of gestation, and 32 babies (10.4%) were born before 32 weeks. Cord blood gas analysis revealed that 19 infants (6.3%) had pH < 7 and base excess (BE) < −12. The rate of perinatal asphyxia was significantly higher in babies born to mothers who did not survive (p = 0.027). A considerable number of infants, 119 (40.3%), were admitted to the neonatal intensive care unit (NICU). Among the seven infants with positive PCR results admitted to the NICU, five (4.2%) did not survive.Conclusion: While COVID‐19 infection in pregnancy seriously affects mortality and morbidity in pregnant women, it also causes mortality and morbidity on the fetus.

9 September 2024 in Ege Tıp Dergisi
Verified
Journal Article
Open access
PDF file
MBMesut Bala
Mesut Bala
MAMustafa Fırat Aydın
Mustafa Fırat Aydın
CBCihan Bademkiran
Cihan Bademkiran
EGErdoğan Gül
Erdoğan Gül
HYHüseyin Yılmaz
Hüseyin Yılmaz
Objective: Previous studies have shown that umbilical cord morphology and its components affect the pregnancy process, mode of delivery, and outcome. Within the scope of this research, we aimed to elucidate and compare placental histological features and perinatal outcomes in all deliveries with or without umbilical cord anomaly. Materials & Methods: A total of 1105 females who had a delivery in our institution have been enrolled in this prospective study. Regarding patient groups, 270 cases were in the study group, and 835 cases in the control group. All patients' demographic data, prenatal information, intrapartum information, postpartum information, postpartum period, and newborn follow-up were recorded. After delivery, umbilical cord abnormalities and placenta macroscopic and microscopy results were monitored prospectively. Results: No placental pathology was detected in the control group, but statistical significance was achieved in the study group, including fetal vascular thrombosis and ectasia pathology and fetal vasculopathy or avascular villi pathology. There was no difference between the study and control groups regarding preeclampsia, ablatio placenta, and intrauterine maternal loss. Intrauterine growth retardation was detected at a higher rate in the study group, and the difference was significant. It was found that the follow-up of the babies of the cases in the neonatal intensive care unit study group was more complicated and required longer treatment. Conclusion: Gros cord anomalies, fetal vascular ectasia and thrombosis, and fetal thrombotic vasculopathy lead to pathologies associated with placental insufficiency, suggesting that it is an independent risk factor for intrauterine growth retardation.